Literature DB >> 22430285

[Cardiac imaging in (asymptomatic) diabetic patients].

M J Zellweger1.   

Abstract

Coronary artery disease (CAD) plays an important role in diabetic patients because they have a very high cardiovascular mortality risk. Therefore the question arises if all diabetic patients should be screened for CAD. In patients with (a)typical angina or anginal equivalents (e.g. shortness of breath) an extended CAD evaluation is indicated. Unselected screening in diabetic patients, however, does not seem to make sense as the only large prospective randomized study in this field did not demonstrate a survival benefit in the screened patient population. It is noteworthy that preoperative risk stratification deserves special consideration in diabetic patients. If screening is considered there is the anatomic approach (calcium score, non-invasive coronary angiography) or the functional approach (stress testing, ischemia evaluation). In diabetic patients who in general should already have all the medication with respect to coronary prevention, functional rather than anatomic testing makes sense because revascularization can be considered in patients with extensive ischemia. In contrast, anatomic testing if positive would only be confirming that a medical preventive strategy is necessary. On the other hand a normal anatomic test has a very high negative predictive value. Therefore, CAD evaluation should follow an individual patient tailored approach as long as evidence-based guidelines are lacking.

Entities:  

Mesh:

Year:  2012        PMID: 22430285     DOI: 10.1007/s00059-012-3601-5

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  42 in total

1.  Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus.

Authors:  X Kang; D S Berman; H Lewin; R Miranda; J Erel; J D Friedman; A M Amanullah
Journal:  Am Heart J       Date:  1999-05       Impact factor: 4.749

2.  Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: a position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology.

Authors:  Pasquale Perrone-Filardi; Stephan Achenbach; Stefan Möhlenkamp; Zeljko Reiner; Gianmario Sambuceti; Joanne D Schuijf; Ernst Van der Wall; Philip A Kaufmann; Juhani Knuuti; Stephen Schroeder; Michael J Zellweger
Journal:  Eur Heart J       Date:  2010-07-14       Impact factor: 29.983

3.  Determinants of coronary calcium conversion among patients with a normal coronary calcium scan: what is the "warranty period" for remaining normal?

Authors:  James K Min; Fay Y Lin; David S Gidseg; Jonathan W Weinsaft; Daniel S Berman; Leslee J Shaw; Alan Rozanski; Tracy Q Callister
Journal:  J Am Coll Cardiol       Date:  2010-03-16       Impact factor: 24.094

Review 4.  Prognostic significance of silent coronary artery disease in type 2 diabetes.

Authors:  Michael J Zellweger
Journal:  Herz       Date:  2006-05       Impact factor: 1.443

5.  Is diabetic retinopathy related to subclinical cardiovascular disease?

Authors:  Ryo Kawasaki; Ning Cheung; F M Amirul Islam; Ronald Klein; Barbara E K Klein; Mary Frances Cotch; A Richey Sharrett; Daniel O'Leary; Tien Y Wong
Journal:  Ophthalmology       Date:  2010-12-18       Impact factor: 12.079

6.  Late acute thrombotic occlusion after endovascular brachytherapy and stenting of femoropopliteal arteries.

Authors:  Robert Bonvini; Iris Baumgartner; Do Dai Do; Mario Alerci; Jeanne-Marie Segatto; Paolo Tutta; Kurt Jäger; Markus Aschwanden; Ernst Schneider; Beatrice Amann-Vesti; Richard Greiner; Felix Mahler; Augusto Gallino
Journal:  J Am Coll Cardiol       Date:  2003-02-05       Impact factor: 24.094

7.  Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction.

Authors:  Chong Do Lee; Aaron R Folsom; James S Pankow; Frederick L Brancati
Journal:  Circulation       Date:  2004-02-02       Impact factor: 29.690

8.  Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study.

Authors:  Frans J Th Wackers; Deborah A Chyun; Lawrence H Young; Gary V Heller; Ami E Iskandrian; Janice A Davey; Eugene J Barrett; Raymond Taillefer; Steven D Wittlin; Neil Filipchuk; Robert E Ratner; Silvio E Inzucchi
Journal:  Diabetes Care       Date:  2007-08-06       Impact factor: 19.112

9.  Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Authors:  Leslee J Shaw; Daniel S Berman; David J Maron; G B John Mancini; Sean W Hayes; Pamela M Hartigan; William S Weintraub; Robert A O'Rourke; Marcin Dada; John A Spertus; Bernard R Chaitman; John Friedman; Piotr Slomka; Gary V Heller; Guido Germano; Gilbert Gosselin; Peter Berger; William J Kostuk; Ronald G Schwartz; Merill Knudtson; Emir Veledar; Eric R Bates; Benjamin McCallister; Koon K Teo; William E Boden
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690

10.  Coronary calcium score and prediction of all-cause mortality in diabetes: the diabetes heart study.

Authors:  Subhashish Agarwal; Timothy Morgan; David M Herrington; Jianzhao Xu; Amanda J Cox; Barry I Freedman; J Jeffrey Carr; Donald W Bowden
Journal:  Diabetes Care       Date:  2011-03-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.